Recommended Urologic Workup for Microscopic Hematuria
The recommended urologic workup for microscopic hematuria includes a comprehensive examination of urinary sediment, testing for proteinuria and infection, upper urinary tract imaging, and cystoscopy, with the specific components determined by risk stratification. 1
Initial Evaluation
- First, confirm true microscopic hematuria with ≥3 red blood cells per high-power field on microscopic examination of at least two properly collected urine specimens 1
- Rule out benign causes including menstruation, vigorous exercise, sexual activity, trauma, and infection - repeat urinalysis 48 hours after cessation of potential benign causes 1, 2
- If hematuria resolves after addressing benign causes, no additional evaluation is warranted 1
- For urinary tract infection, treat appropriately and repeat urinalysis six weeks after treatment; if hematuria resolves, no further workup is needed 1
Risk Assessment and Pathway Determination
Assess for indicators of glomerular bleeding:
Evaluate for risk factors for urologic malignancy:
Diagnostic Pathway for Suspected Glomerular Source
Refer to nephrology for evaluation if any of the following are present:
Nephrology evaluation may include:
- Evaluation for systemic diseases
- Consideration of renal biopsy
- Assessment of renal function 3
Diagnostic Pathway for Non-Glomerular (Urologic) Source
Complete urologic evaluation includes:
Upper tract imaging options include:
- Intravenous urography (IVU) - traditionally the modality of choice but limited in detecting small renal masses 1
- Computed tomography (CT) - best for evaluating urinary stones, renal infections, and has high detection rates for transitional cell carcinoma 1
- Ultrasonography - less sensitive than CT or IVU for detecting transitional cell carcinoma 1, 4
Follow-up Recommendations
- For patients with persistent microscopic hematuria after negative initial evaluation:
Important Clinical Considerations
- The prevalence of microscopic hematuria is approximately 2% in the general population, increasing to around 30% in high-risk groups 5
- Medical or surgical intervention is required in 13-35% of patients with microscopic hematuria 5
- Malignant tumors are found in 2.6-4% of all patients with microscopic hematuria and up to 25.8% in high-risk populations 5
- Studies show that only 36% of primary care physicians refer patients with microscopic hematuria to urologists, despite guideline recommendations 6
- All patients with gross hematuria should be referred for urgent urologic evaluation due to >10% risk of malignancy 7